nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—CYP11B2—cardiovascular system—attention deficit hyperactivity disorder	0.057	0.0974	CbGeAlD
Hydrocortisone—ANXA1—forebrain—attention deficit hyperactivity disorder	0.046	0.0785	CbGeAlD
Hydrocortisone—ANXA1—cardiovascular system—attention deficit hyperactivity disorder	0.0389	0.0664	CbGeAlD
Hydrocortisone—ANXA1—midbrain—attention deficit hyperactivity disorder	0.0304	0.0519	CbGeAlD
Hydrocortisone—SHBG—cardiovascular system—attention deficit hyperactivity disorder	0.026	0.0444	CbGeAlD
Hydrocortisone—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.0255	0.0436	CbGeAlD
Hydrocortisone—ANXA1—nervous system—attention deficit hyperactivity disorder	0.025	0.0426	CbGeAlD
Hydrocortisone—ANXA1—central nervous system—attention deficit hyperactivity disorder	0.024	0.041	CbGeAlD
Hydrocortisone—ANXA1—cerebellum—attention deficit hyperactivity disorder	0.0235	0.0401	CbGeAlD
Hydrocortisone—ANXA1—brain—attention deficit hyperactivity disorder	0.0191	0.0326	CbGeAlD
Hydrocortisone—Testosterone Propionate—COMT—attention deficit hyperactivity disorder	0.018	0.754	CrCbGaD
Hydrocortisone—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.0168	0.0288	CbGeAlD
Hydrocortisone—SHBG—central nervous system—attention deficit hyperactivity disorder	0.0161	0.0274	CbGeAlD
Hydrocortisone—NR3C1—forebrain—attention deficit hyperactivity disorder	0.016	0.0273	CbGeAlD
Hydrocortisone—SHBG—cerebellum—attention deficit hyperactivity disorder	0.0157	0.0268	CbGeAlD
Hydrocortisone—ANXA1—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.0152	0.0388	CbGpPWpGaD
Hydrocortisone—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.0139	0.0237	CbGeAlD
Hydrocortisone—ANXA1—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0136	0.0347	CbGpPWpGaD
Hydrocortisone—NR3C1—cardiovascular system—attention deficit hyperactivity disorder	0.0135	0.0231	CbGeAlD
Hydrocortisone—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.0133	0.0228	CbGeAlD
Hydrocortisone—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.013	0.0223	CbGeAlD
Hydrocortisone—SHBG—brain—attention deficit hyperactivity disorder	0.0127	0.0218	CbGeAlD
Hydrocortisone—ABCG2—midbrain—attention deficit hyperactivity disorder	0.0114	0.0196	CbGeAlD
Hydrocortisone—SLCO1A2—brain—attention deficit hyperactivity disorder	0.0106	0.0181	CbGeAlD
Hydrocortisone—NR3C1—midbrain—attention deficit hyperactivity disorder	0.0105	0.018	CbGeAlD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00933	0.0239	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0091	0.0233	CbGpPWpGaD
Hydrocortisone—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00885	0.0151	CbGeAlD
Hydrocortisone—NR3C1—nervous system—attention deficit hyperactivity disorder	0.00867	0.0148	CbGeAlD
Hydrocortisone—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00855	0.0146	CbGeAlD
Hydrocortisone—NR3C1—central nervous system—attention deficit hyperactivity disorder	0.00834	0.0143	CbGeAlD
Hydrocortisone—ANXA1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00822	0.021	CbGpPWpGaD
Hydrocortisone—NR3C1—cerebellum—attention deficit hyperactivity disorder	0.00816	0.0139	CbGeAlD
Hydrocortisone—CYP2C8—brain—attention deficit hyperactivity disorder	0.0074	0.0126	CbGeAlD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00724	0.0185	CbGpPWpGaD
Hydrocortisone—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00723	0.0123	CbGeAlD
Hydrocortisone—ABCG2—brain—attention deficit hyperactivity disorder	0.00719	0.0123	CbGeAlD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00709	0.0181	CbGpPWpGaD
Hydrocortisone—CYP11B2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0067	0.0172	CbGpPWpGaD
Hydrocortisone—NR3C1—brain—attention deficit hyperactivity disorder	0.00662	0.0113	CbGeAlD
Hydrocortisone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00655	0.0112	CbGeAlD
Hydrocortisone—ANXA1—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00633	0.0162	CbGpPWpGaD
Hydrocortisone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00631	0.0108	CbGeAlD
Hydrocortisone—ANXA1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00618	0.0158	CbGpPWpGaD
Hydrocortisone—Testosterone—MAOA—attention deficit hyperactivity disorder	0.00591	0.247	CrCbGaD
Hydrocortisone—CYP11B1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00578	0.0148	CbGpPWpGaD
Hydrocortisone—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00564	0.00964	CbGeAlD
Hydrocortisone—ANXA1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00551	0.0141	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.0054	0.0138	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0054	0.0138	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00491	0.0126	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00486	0.0124	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00478	0.0122	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00472	0.0121	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00471	0.012	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00464	0.0119	CbGpPWpGaD
Hydrocortisone—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00464	0.00793	CbGeAlD
Hydrocortisone—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00447	0.00763	CbGeAlD
Hydrocortisone—ANXA1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.0044	0.0113	CbGpPWpGaD
Hydrocortisone—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00437	0.00746	CbGeAlD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.0043	0.011	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0043	0.011	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00422	0.0108	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00399	0.0102	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00387	0.0099	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0038	0.00973	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00375	0.00961	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00374	0.00958	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.0037	0.00947	CbGpPWpGaD
Hydrocortisone—CYP11B2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00359	0.00918	CbGpPWpGaD
Hydrocortisone—CYP11B2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00356	0.00911	CbGpPWpGaD
Hydrocortisone—ABCB1—brain—attention deficit hyperactivity disorder	0.00355	0.00606	CbGeAlD
Hydrocortisone—CYP11B2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00354	0.00905	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0035	0.00895	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00331	0.00847	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00327	0.00837	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00311	0.00797	CbGpPWpGaD
Hydrocortisone—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00311	0.00796	CbGpPWpGaD
Hydrocortisone—CYP11B1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00309	0.00791	CbGpPWpGaD
Hydrocortisone—CYP11B1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00307	0.00785	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00305	0.00781	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00305	0.0078	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00304	0.00778	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00294	0.00754	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00289	0.00741	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00286	0.00732	CbGpPWpGaD
Hydrocortisone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00284	0.00727	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00283	0.00724	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00277	0.00709	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00276	0.00705	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00266	0.00682	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00249	0.00637	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00245	0.00627	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00241	0.00616	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00239	0.00612	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00237	0.00606	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00233	0.00595	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00228	0.00584	CbGpPWpGaD
Hydrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—attention deficit hyperactivity disorder	0.00226	0.00579	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.0022	0.00564	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.0022	0.00564	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00211	0.00541	CbGpPWpGaD
Hydrocortisone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00205	0.00526	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00194	0.00498	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00193	0.00493	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00192	0.00491	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00189	0.00485	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00187	0.00477	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00185	0.00473	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00181	0.00462	CbGpPWpGaD
Hydrocortisone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00178	0.00455	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00172	0.0044	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.0017	0.00435	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00168	0.0043	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00167	0.00428	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00166	0.00426	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00166	0.00424	CbGpPWpGaD
Hydrocortisone—NR3C1—Circadian Clock—EP300—attention deficit hyperactivity disorder	0.00165	0.00422	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00164	0.00419	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00164	0.00419	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00164	0.00419	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00162	0.00413	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00161	0.00411	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.0016	0.00409	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00156	0.00399	CbGpPWpGaD
Hydrocortisone—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00152	0.00389	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00151	0.00387	CbGpPWpGaD
Hydrocortisone—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00151	0.00386	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00151	0.00385	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0015	0.00384	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00149	0.0038	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00147	0.00375	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00147	0.00375	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00142	0.00362	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00137	0.0035	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00136	0.00348	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00135	0.00346	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00126	0.00323	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—attention deficit hyperactivity disorder	0.00121	0.0031	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—attention deficit hyperactivity disorder	0.0012	0.00306	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00113	0.0029	CbGpPWpGaD
Hydrocortisone—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0011	0.00281	CbGpPWpGaD
Hydrocortisone—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00109	0.00279	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00108	0.00277	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00105	0.0027	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00102	0.00262	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00101	0.00259	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00101	0.00259	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000996	0.00255	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000992	0.00254	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000977	0.0025	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000957	0.00245	CbGpPWpGaD
Hydrocortisone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000955	0.00244	CbGpPWpGaD
Hydrocortisone—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000952	0.00244	CbGpPWpGaD
Hydrocortisone—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000945	0.00242	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000939	0.0024	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000926	0.00237	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000922	0.00236	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000893	0.00228	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000878	0.00225	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000872	0.00223	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000872	0.00223	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000867	0.00222	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000858	0.0022	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000832	0.00213	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000809	0.00207	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000807	0.00207	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000798	0.00204	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000792	0.00203	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00077	0.00197	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000765	0.00196	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000731	0.00187	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000716	0.00183	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000716	0.00183	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000697	0.00178	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000664	0.0017	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000659	0.00169	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000627	0.00161	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000622	0.00159	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000613	0.00157	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000609	0.00156	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000591	0.00151	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000565	0.00145	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000547	0.0014	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000547	0.0014	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000538	0.00138	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000528	0.00135	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000525	0.00134	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000511	0.00131	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000509	0.0013	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000507	0.0013	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000504	0.00129	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.0005	0.00128	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00045	0.00115	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000437	0.00112	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000433	0.00111	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000433	0.00111	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000429	0.0011	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000429	0.0011	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000426	0.00109	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000422	0.00108	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000416	0.00107	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000396	0.00101	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000393	0.001	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000389	0.000996	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000356	0.000912	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000346	0.000886	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000343	0.000878	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000339	0.000868	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000331	0.000848	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00033	0.000843	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000329	0.000842	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000327	0.000837	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000327	0.000836	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000319	0.000817	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00031	0.000794	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00031	0.000794	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000305	0.000781	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.0003	0.000767	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000284	0.000726	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000269	0.000688	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000269	0.000688	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000264	0.000677	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000263	0.000673	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000262	0.000671	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000261	0.000667	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.00026	0.000666	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000258	0.000661	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000248	0.000635	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000246	0.000629	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000236	0.000604	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000234	0.000599	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000234	0.000599	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00023	0.00059	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000227	0.00058	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000215	0.00055	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000214	0.000548	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000209	0.000535	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000205	0.000523	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000188	0.000481	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000187	0.000479	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000187	0.000478	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000178	0.000456	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000163	0.000417	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000162	0.000414	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000157	0.000401	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000144	0.000369	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000144	0.000369	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000142	0.000364	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000142	0.000363	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000142	0.000363	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000141	0.00036	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000132	0.000338	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000115	0.000295	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000113	0.000288	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000112	0.000285	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.000281	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.74e-05	0.000224	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.68e-05	0.000222	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	8.06e-05	0.000206	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	6.98e-05	0.000179	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	6.08e-05	0.000156	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.75e-05	9.59e-05	CbGpPWpGaD
